A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alzheimer’s disease.
New antibody shows promise in reducing tau proteins associated with Alzheimer’s disease
- Post author:
- Post published:October 5, 2023
- Post category:uncategorized